Group (n± S.D.) Group-1 Group-2 Group-3 P value
Mean follow-up in months 19.34 ±4.2 20.60 ±3.67 20.55 ±3.23  
Patient survival 100 % 100 % 100 % 1
Graft survival 100 % 100 % 93.3 % 0.13
Mean serum creatinine (mg/dL)  
1 month 1.33  ±0.3 1.33  ±0.22 1.31  ±0.3 0.2
3 months 1.32  ±0.3 1.33  ±0.19 1.22  ±0.25 0.21
6 months 1.30  ±0.33 1.33  ±0.28 1.37  ±0.56 0.8
9 months 1.29  ±0.32 1.37  ±0.46 1.25  ±0.23 0.46
12  months 1.29  ±0.36 1.36  ±0.4 1.24  ±0.27 0.40
15  months 1.15  ±0.29 1.28 ±0.21 1.27 ±0.36 0.49
18 months 1.23   ±0.32 1.38 ±0.26 1.2 ±0.25 0.25
Biopsy        
AR <ag1 at1 av1 ai2 ptc 0 2 3 2 0.85
≥ ag1 at1 av1 ai2 ptc0 0 2 5 <0.01
≥cg1 ct1 cv1 ci2 ptc 0 0 0 1 0.36
Tregs in peripheral blood
3 months 3.51 ± 0.55 3.28 ± 0.67 1.58 ± 0.62 <0.01
6 months 3.12 ± 0.71 2.94 ± 0.7 1.43 ± 0.37 <0.01
9 months 3.16 ± 1.14 2.93 ± 0.85 1.76 ± 1.07 <0.01
12  months 3.09 ± 1.04 2.96 ± 1.18 1.84  ± 0.77 <0.01
15  months 3.02 ±  0.44 2.98 ± 0.77 1.98 ± 0.93 <0.01
18 months 3.52 ± 0.84 3.19 ± 0.49 2.09 ± 0.86 <0.01
Two immunosuppressants 30 (100%) 28 (93.3%) 0 <0.01
    Three immunosuppressants 0 02 (6.7%) 30 (100%) <0.01
Table 2: Follow-up after transplantation.